Cargando…
HAIC as a potential therapy for esophageal cancer patients with liver metastasis: a retrospective cohort study
METHODS: This was a single-arm historical cohort study of ESCC patients with synchronous or heterochronous LM between December 2014 and July 2021 at the Department of Gastrointestinal Oncology. The patients were treated with HAIC for LM, and regular image assessments were performed according to the...
Autores principales: | Dong, Fengxiao, Cao, Guang, Lu, Zhihao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196257/ https://www.ncbi.nlm.nih.gov/pubmed/37215706 http://dx.doi.org/10.3389/fmed.2023.1143617 |
Ejemplares similares
-
Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE?
por: Ge, Naijian, et al.
Publicado: (2023) -
Safety study of Folfox-HAIC in relieving bed restriction
por: Zhao, Xiaoyun, et al.
Publicado: (2021) -
Development and validation of prognostic nomograms for large
hepatocellular carcinoma after HAIC
por: Yao, Wang, et al.
Publicado: (2023) -
HAIC versus TACE for patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Liu, Junguo, et al.
Publicado: (2022) -
Association between ADAMTS13 activity–VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma
por: Takaya, Hiroaki, et al.
Publicado: (2020)